» Articles » PMID: 7626114

A Novel Highly Specific and Potent Inhibitor of Calmodulin-dependent Protein Kinase II

Overview
Publisher Elsevier
Specialty Biochemistry
Date 1995 Jul 26
PMID 7626114
Citations 119
Authors
Affiliations
Soon will be listed here.
Abstract

A novel synthetic peptide AIP (autocamtide-2-related inhibitory peptide), a nonphosphorylatable analog of autocamtide-2, was found to be a highly specific and potent inhibitor of calmodulin-dependent protein kinase II (CaM-kinase II). It was 50 and 500 times more potent than CaMK-(281-302Ala286) and KN-93, respectively, under the assay conditions used. The inhibition was unaffected by the presence or absence of Ca2+/calmodulin, and it was competitive with autocamtide-2 and noncompetitive with syntide-2. AIP (1 microM) completely inhibited CaM-kinase II activity, but did not affect cyclic AMP-dependent protein kinase, protein kinase C, calmodulin-dependent protein kinase IV, and unidentified protein kinases occurring in a rat brain extract. These results indicate that AIP is a useful tool for studying the physiological roles of CaM-kinase II.

Citing Articles

CaMKII-dependent non-canonical RIG-I pathway promotes influenza virus propagation in the acute-phase of infection.

Hama S, Watanabe-Takahashi M, Nishimura H, Omi J, Tamada M, Saitoh T mBio. 2024; 16(1):e0008724.

PMID: 39601535 PMC: 11708044. DOI: 10.1128/mbio.00087-24.


Competitive processes shape multi-synapse plasticity along dendritic segments.

Chater T, Eggl M, Goda Y, Tchumatchenko T Nat Commun. 2024; 15(1):7572.

PMID: 39217140 PMC: 11365941. DOI: 10.1038/s41467-024-51919-0.


Studying CaMKII: Tools and standards.

Brown C, Bayer K Cell Rep. 2024; 43(4):113982.

PMID: 38517893 PMC: 11088445. DOI: 10.1016/j.celrep.2024.113982.


Hippocampal CaMKII inhibition induces reactivation-dependent amnesia for extinction memory and causes fear relapse.

Radiske A, de Castro C, Rossato J, Gonzalez M, Cammarota M Sci Rep. 2023; 13(1):21712.

PMID: 38066022 PMC: 10709345. DOI: 10.1038/s41598-023-48454-1.


Role of CaMKII in diabetes induced vascular injury and its interaction with anti-diabetes therapy.

Chacar S, Abdi A, Almansoori K, Alshamsi J, Al Hageh C, Zalloua P Rev Endocr Metab Disord. 2023; 25(2):369-382.

PMID: 38064002 PMC: 10943158. DOI: 10.1007/s11154-023-09855-9.